Cocrystal Pharma GAAP EPS of -$0.19 beats by $0.02
Source: SeekingAlpha
2025-11-14 08:11:20 ET
More on Cocrystal Pharma
- Cocrystal Pharma announces up to $13 million registered direct offering
- Seeking Alpha’s Quant Rating on Cocrystal Pharma
- Historical earnings data for Cocrystal Pharma
- Financial information for Cocrystal Pharma
Read the full article on Seeking Alpha
For further details see:
Cocrystal Pharma GAAP EPS of -$0.19 beats by $0.02
Cocrystal Pharma Inc.
NASDAQ: COCP
COCP Trading
3.02% G/L:
$1.065 Last:
20,526 Volume:
$1.04 Open:
COCP Latest News
March 09, 2026 08:00:00 am
First Subjects Dosed in Cocrystal Pharma's Phase 1b Study Evaluating CDI-988 for Norovirus Prevention and Treatment
February 19, 2026 08:00:00 am
Cocrystal Pharma's First Oral Norovirus Protease Inhibitor CDI-988 to be Featured at the International Society for Antiviral Research Conference (ICAR) 2026
COCP Stock Data
$13,370,543
9,905,229
0.18%
11
N/A
Biotechnology & Life Sciences
Healthcare
US
Bothell
